Nutriband Inc. (NASDAQ:NTRBW – Get Free Report) traded down 9.7% on Thursday . The company traded as low as $1.40 and last traded at $1.40. 8,275 shares traded hands during mid-day trading, an increase of 183% from the average session volume of 2,922 shares. The stock had previously closed at $1.55.
Nutriband Stock Down 9.7%
The business’s fifty day moving average is $1.56 and its two-hundred day moving average is $1.71.
Institutional Investors Weigh In On Nutriband
An institutional investor recently bought a new position in Nutriband stock. Clear Street Group Inc. purchased a new stake in Nutriband Inc. (NASDAQ:NTRBW – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 61,590 shares of the company’s stock, valued at approximately $105,000.
Nutriband Company Profile
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.
Recommended Stories
- Five stocks we like better than Nutriband
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- New gold price target
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
